NOVATO, Calif. -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism (SSIEM), August 31st-In

read more>>

NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today it will regain full worldwide rights to develop and commercialize rindopepimut (CDX-110), effective November 1, 2010Celldex and Pfizer Vaccines LLC entered into a global development and commercialization agreement in April

read more>>

GENEVA, Switzerland -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1Cladribine Tablets will be registered in A

read more>>

Liestal, Switzerland and Paris, France -- Santhera Pharmaceuticals (SIX: SANN) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced a license agreement for the development and commercialization of fipamezole (antagonist of the adrenergic al-pha-2 receptor) for territories outside of North America

read more>>

Princeton, NJ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financingProceeds will support comple

read more>>

SCOTTSDALE, Ariz. -- Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11Urologists from Scottsdale Healthcare will be available to answer questions and

read more>>

Counterfeiting of drugs is a huge industry with an annual turnover of more than SEK 500 billionIn Africa the situation is extremely serious. Half of the malaria medication sold there could be ineffective or even harmful. Researchers from Lund and the UK have now developed a technique that could re

read more>>

WASHINGTON -- Members of the Prostate Cancer Roundtable, consisting of America's Leading Prostate Cancer Organizations, are asking President Obama to place a blue ribbon on the White House and light the White House blue in the evenings in recognition of Prostate Cancer Awareness Month in September

read more>>

RESTON, Va.— A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphomaAccording to researchers, molecular

read more>>

SANTA MONICA, Calif. - Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific "De

read more>>